
1. Department of Pathology, Duke University School of Medicine, Durham, NC, USA
2. Duke Cancer Institute, Durham, NC, USA
Lymphoma; Biomarker; Molecular and genetic profiling

Houston Methodist Hospital and Houston Methodist Research Institute, Houston TX, USA
Oocytes; Germ cells; Localized RNA; Actin; Macrophages; Immune cells; Mechanotransduction; Allograft rejection; Transplantation; Anti-rejection therapies
Tenured Associate Professor in the Department of Zoology at the University of Warsaw
Research Associate in the Department of Biology at Carleton University in Ottawa
Associate Professor in the Department of Biochemistry and Molecular Biology there in 2006.
Distinguished Fellow of the Kosciuszko Foundation in 2014
Fulbright Senior Specialist Grant Award in 2003
Research Scientist in University of Texas M.D. Anderson Cancer Center in 1987
The MRC Biotechnology Training Award from Dalhousie University in1985
The AHFMR Research Award from the University of Calgary in 1982

Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine—National Research Institute (WIM-PIB), Szaserow, Poland;
Institute of Genetics and Development of Rennes, Faculty of Medicine, University of Rennes, Rennes, France
Cancers; Cell cycle regulation; Embryology and development; Kinases; Oocytes; Phosphatases
Professor of Institute of Genetics and Development of Rennes, Faculty of Medicine, University of Rennes
Director of Dynamics and Mechanics of Epithelia Group, Institute of Genetics and Development of Rennes (IGDR)
Director of National Centre for Scientific Research (CNRS), Faculty of Medicine
Full-time Researcher at the National Centre for Scientific Research (CNRS)

Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Berlin, Germany
Neurology; Psychiatry; Pain; Parkinson's disease; Multiple sclerosis
Professor and Head of the Department of Neurology, St. Joseph Hospital Berlin‑Weißensee (Alexianer), Germany, with authorization to train for certification in Neurology (36 months)
Chief Physician (Chefarzt), Clinic for Neurology, St. Joseph Hospital Berlin‑Weißensee, specializing in Multiple Sclerosis and Parkinson’s disease care and research
Recognized as a leading regional and national expert in MS and Parkinson’s disease, based on long-term contributions and clinic development
Awarded the PRIMO MEDICO quality seal (2019 and ongoing), signifying top-tier medical expertise in the German-speaking region
Led the designation of the clinic as a DMSG-certified MS Centre of Excellence (as of October 1, 2019), awarded by the German Multiple Sclerosis Society

Department of Radiation Oncology, Hospital Universitario Quirónsalud, Madrid, Spain
Oncology; Pulmonology; Radiology and radiotherapy; Pharmacology
Medical Director of GenesisCare Spain, Spain. Interests are Prostate Cancer, Lung Cancer, Adaptive radiotherapy , Next Generation Imaging and Molecular Biomarkers.

Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands
Gastroenterology; Hepatology; Oncology; Experimental surgery
Resident (AIOS) - Gastroenterology & Hepatology, Leiden University Medical Centre / HMC in 2019-present
SHO - Transplant Hepatology/General Gastroenterology, Leiden University Medical Centre in 2018
Visiting Scientist - University of Calgary in 2014

Department of Pharmacology, Toxicology & Therapeutics, Kansas University Medical Center, University of Kansas, Kansas, USA
Hepatology; Pharmacology and toxicology
Professor (Full), Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center
Distinguished Professor, Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center
Former Chairman, Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center.
More than 520 publications. His research interests include basic mechanisms and translational aspects of drug hepatotoxicity and tissue repair, especially acetaminophen overdose, and mechanisms of inflammatory liver injury in animal models and humans.

Department of Family Medicine and Community Health, University of Miami Miller School of Medicine, Miami, USA
Exercise physiology; Nutrition; Physiology; Dietary supplements
Voluntary Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
Diplomate, Faculty Member, and Advisor, Medical Wellness Association, Houston, TX, USA
Founder and President, Dr. Lewis Nutrition

Department of Microbiology Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada
Antiviral innate immunity; Herpesviruses; Viral immune evasion mechanism; Emerging viruses; Signaling pathways; Virus-Host interaction
Elsevier's Top 0.5% (2023) and Top 1% (2021-2022) Scientists
Adjunct Professor at the University of Calgary, Calgary, Canada.
Editor of mBio, an Associate Editor of Virology Journal, etc.
Awards: Hundred-Talent Program of the Chinese Academy of Sciences
Top 25 reviewers for the Journal of Virology (2019, 2020, 2021, 2022)
the Publons Top 1% Peer Reviewers (2019-2020)
Excellent Editors of ASM (mBio), Springer Nature and Frontiers.

Baylor College of Medicine, Houston, Texas, USA
Acute myocardial infarction; Coronary artery disease; Hypertrophic obstructive cardiomyopathy; Interventional cardiology; Ischemic heart disease; Percutaneous coronary and peripheral intervention; Peripheral arterial disease; Valvular heart disease

Department of Medicine, Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care Center and Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, USA
Blood-brain barrier; Neurodegeneration; Neuroimmunology; Pathophysiology and treatment of type 2 diabetes; Traumatic brain injury

Department of Psychology, Center for Studies and Research in Cognitive Neuroscience, University of Bologna, Bologna, Italy
Clinical neuropsychology; Clinical neuroscience; Cognition disorders; Cognitive neuropsychology; Cognitive neuroscience; Executive function; Memory; Neuropsychological assessment

Laboratoire Signalisation et Transports Ioniques Membranaires, Université de Poitiers, CNRS, Poitiers, France
Biochemistry; Cystic fibrosi;s Electrophysiology; Human physiology; Patch clamp; Patch clamp recording; Patch-Clamp electrophysiology; Pharmacology; Stem cell biology
School of Clinical Medicine, UNSW Sydney, Sydney, Australia
Neurology; Public health; Sleep medicine; Concussion; Epilepsy; Legal medicine; Medical education; Neuroepidemiology
Roy G. Beran is trained as a consultant neurologist and accredited sleep physician, in addition to working within legal medicine, military medicine and aviation medicine. His qualifications include: MBBS, MD, FRACP, FRACGP, Grad. Dip. Tertiary Ed., Grad. Dip. Further Ed., FAFPHM, FACLM, FRCP, FAAN, FACBS, B Leg. S, MHL and FFFLM (Hon). His Orcid ID is 0000-0002-5884-0606. He is registered with the Australian Health Practitioner Regulation Agency (AHPRA) as a specialist in Neurology, Public Health and Sleep Medicine and was a Designated Medical Examiner for the Civil Aviation Safety Authority, a medical assessor for Dispute Resolution for the State Insurance Regulatory Authority and an assessor for the Workers Compensation Commission of New South Wales (NSW). He is a Conjoint Professor of Medicine at the University of NSW; Professor in the School of Medicine at Griffith University, Queensland; and Professor, Chair, Medical Law, Sechenov Moscow 1st State University, Moscow, Russia. Following Russia’s invasion of Ukraine, he refused to re-sign the agreement with Sechenov University. He was the inaugural Visiting Professor at the International Research Institute of Health Law Sciences at the Southern Medical University, Guangzhou, Guangdong Province, China. In 2022, he was appointed as a Conjoint Professor in the School of Medicine at the Western Sydney University, in addition to the above appointments.

Department of Neuroradiology, Istituto Clinico Città di Brescia, Brescia, Italy
Ozone therapy; Neuroradiology; Oxygen-ozone therapy; interventional neuroradiology; Low back pain; Disc herniation; Degenerative disc disease; Image-guided therapy; CT-guided procedures; Intradiscal injection; Spine intervention

School of Medicine, Tokai University, Isehara, Japan
Hematopathology; Histopathology; Immune microenvironment; Immuno-oncology; Molecular pathology

Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China
Genomics; Proteomics; Drug repurposing; Bioinformatics; Next-generation sequencing; Cancer biomarker; Evidence-based medicine; Extracellular vesicles; MicroRNA; Molecular diagnostics; Non-coding RNAs; Nasopharyngeal carcinoma; Non-small cell lung cancer
Dr. William Cho is a biomedical scientist at the Department of Clinical Oncology, Queen Elizabeth Hospital in Hong Kong. With a strong background in cancer biomarker discovery and translational research, Dr. Cho has published extensively in peer-reviewed journals. His research interests include genomics, proteomics, and liquid biopsy in oncology. He actively serves on editorial boards and is a frequent reviewer for international scientific journals.

Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Canada
Pharmacokinetics; Drug Delivery; Pharmaceutics; Pharmacology; Toxicology
Dr. Neal M. Davies received his undergraduate degree in Pharmacy from the University of Alberta in 1991. In 1996, he completed his Ph.D. in pharmaceutical sciences, specializing in pharmacokinetics, at the University of Alberta. From 1995 to 1998, he undertook postdoctoral training in pharmacology and toxicology at the University of Calgary. He then joined the University of Sydney as a lecturer in 1998. In 2002, he returned to North America to join the Washington State University’s (WSU) College of Pharmacy as an academic staff member, where he has held the positions of Director of the Pharmaceutical Sciences Graduate Program, as well as Director of Professional and Undergraduate Research and Director of Summer Undergraduate Research Fellowship program. He has been active on numerous university-wide committees, including service as a member of WSU’s Faculty Senate and Chair of the Institutional Animal Care and Use Committe. From 2011-2016 he was Dean of the Faculty of Pharmacy at the University of Manitoba. Under his direction he has been involved in several administrative and operational initiatives including: strategic planning, faculty accreditation review processes; and development of a first professional degree in Pharmacy (PharmD) program. He played key roles in faculty and graduate student recruitment and success and development of Pharmaceutical Analysis Laboratory (PAL). Throughout his career, Dr. Davies has strived to maintain the highest standard of teaching and research, and his achievements in both areas have been recognized through numerous awards and honours including several from the United States Pharmacopeia and the Canadian Society of Pharmaceutical Sciences. He has taught at the undergraduate and graduate levels, and has an ongoing and significant commitment toward graduate supervision and training. He has been at the forefront of the use of technology in the classroom, has re-engineered curricular content and maintained a high standard in student mentoring. Dr. Davies also maintains an active and highly collaborative externally-funded research program, focused on pharmacokinetics and drug delivery as well as basic and clinical pharmaceutical sciences which have attracted National Institutes of Health and Industry funds. He holds five patent applications and has disseminated his work broadly through numerous journal publications, a book and book chapters, abstracts, and invited conference presentations. He has ~8000 citations and an H-index >50. Dr. Davies has been a registered pharmacist with the Alberta College of Pharmacists since 1991. He is active in numerous professional organizations/associations, including the Canadian Society of Pharmaceutical Sciences and the American Association of Pharmaceutical Scientists, and serves as a reviewer and on the editorial board of several pharmaceutical and pharmacological science journals. Over the past decade Dr. Davies has also been heavily involved in pharmacy education research including curriculum mapping, interprofessional education, online teaching, and implementing expanded scopes of practice programs. On September 1, 2016 Dr. Davies commenced his term as Dean and Professor in the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta.

Cardiac Surgery ICU, Onassis Cardiac Surgery Center, Athens, Greece
Acute kidney injury; Cardiopulmonary exercise testing; Cardiopulmonary rehabilitation programs; Chronic heart failure; ECMO; ICU sonography; Intensive care unit acquired weakness; Left ventricle assist device; Neuromuscular electrical stimulation; Pulmonary arterial hypertension; Sepsis

Department of Biostatistics, George Washington University, Washington, DC., USA
Alzheimer's disease and related dementias; Health disparities and health outcomes in older adults; Latent vari; Longitudinal data analysis; Methods to strengthen causal inference in observational research

Department of Ultrasound Medicine, Peking University Third Hospital, Beijing, China.
Superficial ultrasound; Abdominal ultrasound; Elasticity and ultrasound intervention; Transrectal prostate ultrasound; Ultrasound contrast imaging; Ultrasound image artificial intelligence recognition; Ultrasound medicine; Vascular ultrasound

Department of Internal Medicine, Hospital “A. Maresca”, Torre del Greco, Naples, Italy
Obesity; Metabolic syndrome; Physical activity; Energy expenditure; Clinical nutrition

Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
Biochemistry and molecular biology of transglutaminases; Neurodegeneration; Neuroinflammation

Head of Cancer Research Institute (CRI) & Director of the BioSpectroscopy Core Research Laboratory (BCRL) at California South University (CSU), Irvine, California, USA
Biomedical spectroscopy; Biomolecular spectroscopy; Biophysical chemistry
Prof. Dr. Alireza Heidari, Ph.D., D.Sc.
Full Distinguished Professor and Academic Tenure of Chemistry
Enrico Fermi Distinguished Chair in Molecular Spectroscopy
Head of Cancer Research Institute (CRI)
Director of the BioSpectroscopy Core Research Laboratory (BCRL)
Faculty of Chemistry, California South University (CSU), Irvine, California, USA
Board Member of the World Association of Theoretical and Computational Chemists (WATOC)
Continuous Member of the American Association for Cancer Research (AACR), Philadelphia, Pennsylvania, USA
Continuous Member of the American Society for Biochemistry and Molecular Biology (ASBMB), Rockville, Maryland, USA
President of the American International Standards Institute (AISI), Irvine, California, USA

Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, USA
Age-related macular degeneration; Central serous retinopathy; In vitro study; Myopia; Ocular melanocytes; Ocular pigment cells; Proliferative vitreoretinopathy; Retinitis pigmentosa; Uveal melanoma; Uveitis

Hamilton Glaucoma Center and Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, USA
Alzheimer’s disease; Glaucoma; Glial cells; Mitochondrial dysfunction; Mitochondrial protection; Neuroinflammation; Oxidative stress; Retinal ganglion cell

College of Medicine, Medical University of South Carolina, Charleston, USA
Cerebral ischemia and reperfusion; Lipid signaling in neurodegenerating and demyelinating diseases; Neuropharmacology of CNS trauma; Permanent ischemia; Role of oxidative stress and reactive lipids in neurodegenerative diseases; Spinal cord injury; Stroke; Traumatic brain injury

Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China
Otomicrosurgery and hearing reconstruction; Artificial auditory technology; Basic and clinical studies on allergic Rhinitis; Gene Therapy for Deafness; Surgeries in otolaryngology, head and neck

Department of Pathology, Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China
Nasopharyngeal carcinoma; Oncology; Metastasis; EMT; Cancer stem cell; Invasion; Prognosis; Experimental pathology; Ecological pathology; Medical ecology tree; Nasopharyngeal carcinoma ecology

Department of Surgery and Medical-Surgery Specialties, University of Catania, Italy
Cognitive disorders; COVID-19; Geriatrics; Neurology; Neuroscience; Psychiatry & Psychology; Rehabilitation; Translational medicine; Cerebrovascular diseases; Dementia; Neurosonology; Non-invasive brain stimulation; Sleep disorders
Full Professor of Advanced Medical and Surgical Technical Sciences, University of Catania, Italy
Consultant Neurologist & Chief, Clinical Neurophysiology Research Unit, Oasi Research Institute‑IRCCS (a WHO Collaborating Centre), Troina, Italy
Assistant Professor (Senior Academic Researcher), University of Catania
Visiting Clinical Research Fellow, Department of Neuroscience & Clinical Neurophysiology, Newcastle University, UK
Scientific Fellow selected by the European Federation of Neurological Societies (EFNS), 2013
International award for translational research in sleep medicine

Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for CVDs, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
Cardiology; Cardiovascular diseases; Coronary; Angiography; Dyslipidemia hypertension

Department of Emergency General and Trauma Surgery, Aintree University Hospital, NHS University Hospitals of Liverpool Group, UK
Clinical outcomes; Descriptive epidemiology; Emergency gastrointestinal surgery; Gallbladder surgery; Global health; Subtotal cholecystectomy; Trauma surgery

Department of Histology and Embryology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
Pathology; Histology; Veterinary histology

Texas Biomedical Research Institute, San Antonio, USA
Immunology; Virology; Vaccines; Virus-host interactions
Dr. Martinez-Sobrido is continuing his work with the New York Influenza Center of Excellence, which is part of the National Institute of Allergy and Infectious Diseases Centers of Excellence for Influenza Research and Surveillance (CEIRS) program through the National Institutes of Health. In addition to characterizing the influenza virus, as part of this project, he is working with collaborators to develop a universal flu vaccine with the use of broadly neutralizing antibodies (bNAbs) or blood proteins that can recognize key pieces of the virus to help a person’s immune system clear infected cells from the system. Studies are underway to test these bNAbs in small animal models and suitable candidates will move into nonhuman primate models.

Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Manitoba, Canada
Cerebellar circuit formation; Cerebellar gene expression pattern; Cerebellar neurodegeneration pattern; Genetic regulation in cerebellar development; Neurogensis/Axonogensis; Neuronal migration; White matter degeneration

Research Unit of Health Science and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland
Biomarkers of osteoarthritis; Biomimetic joint-on-chip platforms; Cartilage biology; Cellular metabolism; Ion channel physiology
Professor of Musculoskeletal Biology in the Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Finland
Chief Researcher and International Adviser at the State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
Previously President of the Osteoarthritis Research Society International (OARSI)
Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Scientific Collaborator at the Université de Liège
Active member of OARSI and the International Cartilage Regeneration & Joint Preservation Society (ICRS), serves on the Translational Science Committee.
Editorial Board of Osteoarthritis and Cartilage (Elsevier)
Editorial Boards of Osteoarthritis and Cartilage Open (Elsevier) and Osteoarthritis Imaging (Elsevier) and Scientific Reports (Springer Nature).
Published over 400 scientific articles, h-index: 78 (Scopus)

Department of Cardiac and Thoracic Vascular Surgery, UKSH Campus Luebeck, Luebeck, Germany
Aging of the heart; Atrial fibrillation; Cardiovascular diseases; Embryogenesis; Epidemiology of aortic and aortic valve disease; Evaluation and validation of drugs and biomarkers

Department of Pediatrics, Division of Neonatal-Perinatal Medicine, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA
Acute lung injury (ALI)/ARDS; Bronchopulmonary dysplasia (BPD); Cytochrome P450 regulation; Mechanisms of hyperoxic lung injury

Department of Internal Medicine, University of Genova, Genova, Italy
Pharmacogenomics; Immunology; Vaccines; Biologics; HIV; Allergies; Atherosclerosis; Autoimmunity; Immune-mediated diseases; Immunodeficiency; Neuroendocrine-immunology
Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy).
His research has included Immunodeficiency Autoimmunity Neuro-endocrino-immunology Pharmacogenomics.
Based on this research and fellowship training he has received several awards and honors, such as:
Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001).
Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-? and IL-4 ".

Department of Clinical and Biological Science, University of Turin, Turin, Italy
Biocompatibility of materials for medical devices; Cancer biology; Cancer resistance; Lipid aldehydes; Lipid peroxidation; Osseointegration of dental implants; Oxidative stress; PPARs; Tissue regenerations

Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Florence, Italy
Organic chemistry; Drug design; Enzyme modulators; Enzymology; GPCR; Molecular dynamics; Molecular modelling; Spectroscopy; Structure-based design

Department of Medicine, Laboratory Medicine, University of Padova, Padua, Italy
Biomarkers in psoriatic arthritis; Diet in rheumatic diseases; Pathogenetic mechanisms in crystal-induced inflammation; Synovial fluid analysis; The role of calcium crystals in osteoarthritis

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
Molecular dynamics; Molecular docking; Virtual screening; Molecular modeling; Structure-based drug design and discovery; Cancer biology; Glioma; Glioblastoma multiforme (GBM); Molecular biology; Animal studies

Department of Medicine, The University of British Columbia, Vancouver, Canada
Clinical electrophysiology; Heart failure; Signal transduction and vascular disease; Translation medicine
Dr Simon Rabkin is a Professor of Medicine in the Division of Cardiology at the University of British Columbia (UBC). He graduated with an MD from the University of Manitoba. He did post graduate training in Internal Medicine and Cardiology at the University of Toronto, University of Cincinnati and Emory University. His research interests are in the determinants of cardiovascular disease and its therapy. His research interests and activities have spanned the range from basic science, clinical investigation, clinical trials and epidemiology. He has published over 200 scientific papers or book chapters. He has served on many grant review committees. He has served on many Canadian consensus conferences for the development of best practice guidelines for Canadian Physicians. He is the current chair of the subcommittee on the pharmacologic management of patients with hypertension and cardiac disease for the Canadian Hypertension Education Program (CHEP). Dr Rabkin is a past president of the Canadian Hypertension Society and was the President of the 23rd Scientific Meeting of the International Society of Hypertension in 2010.

Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, USA
Autophagy; Nanotechnology; Pharmacology; Toxicology; Biochemistry; Pancreatic cancer; Stem cells; Immunology; Autophagy; Biomarker development; Cancer therapy diabetes
Dr. Srivastava has served as a professor and eminent scientist in major US Universities. He has been proclaimed as an eminent scholar by the Kansas Bioscience Authority, and endowed professor at KUMED. The list of accolades and awards conferred on him is huge and rightly deserved too as he has been a pioneer in some trailblazing subjects when it comes to research. He has received national merit awards and scholarships during his graduate and postgraduate studies. He was awarded fellowships at the National Institutes of Health, and the National Academy of Sciences, USA, and a Career Development Award from the US Army. Furthermore, he has been rightly touted as a Scholar by Louisiana Cancer Research Consortium.

Department of Cardiothoracic & Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, USA
Cardiac surgery; Tissue engineering; Heart-lung transplantation; Mechanical circulatory support; Regenerative medicine

Department of Family and Preventive Medicine, Emory University, Atlanta, USA
Chronic disease; Hypertension; Risk factors; Diet; Diabetes prevention; Lifestyle change; Diabetes and cardiovascular epidemiology; Implementation science; Prediabetes; Prevention; Primary care
Sathish Thirunavukkarasu is an Assistant Professor at the Department of Family and Preventive Medicine, Emory School of Medicine. Sathish completed his Medical Degree, Diploma in Family Medicine, and Master's Degree in Public Health in India and received a PhD in Diabetes Epidemiology from the University of Melbourne in Australia. After his PhD, he did two years of Postdoctoral training at Nanyang Technological University in Singapore and three more years at McMaster University in Canada.
His primary research focuses on the epidemiology of type 2 diabetes and its prevention by developing novel interventions. He is also keen on translating the evidence from research into clinical and public health practice. Sathish has published research articles in very high-impact, leading medical and global health journals such as Nature Reviews Endocrinology, The Lancet Diabetes & Endocrinology, The Lancet Global Health, Diabetes Care, and PLoS Medicine as the lead author.

"Valle d'Itria" Hospital, Martina Franca, Taranto, Italy
Gynecological cancer; Laparoscopy; Surgery
Specialized in Obstetrics and Gynecology at the University Medical School of Bari. Professional Training in Gynecological Laparoscopy at the Center for Advanced Pelvic Surgery and National Center for Endometriosis (European Gynecologic Endoscopic School), Malzoni Medical Center, Avellino, Italy, directed by Dr Mario Malzoni. National Authorirization as Associate Professor in Obstetrics and Gynecology.

Department of Research, Fondazione Paolo Procacci, Roma, Italy
Pain medicine; Pain assessment; Pain management; Acute pain; Chronic pain; Pain research; Comorbidity; Anesthesiology
President of the World Institute of Pain President, Paolo Procacci Foundation General Manager, ASL Teramo, Public Company of the National Health Care Service President of the European Pain Federation (EFIC) President of Clinicians Council, UNIVAQ Full Professor, Anesthesia and Pain Medicine, UNIVAQ Assoc. Professor of Anesthesia and Pain Medicine, UNIVAQ Chairman, Dept. of Anesthesia, UNIVAQ Invited Professor, Dept. of Anesthesia, University of Barcelona, Spain Invited Professor, Dept. of Anesthesia, University of Massachusetts, Worchester, MA, USA; and University of Tel-Aviv, Israel Assist. Professor of Anesthesia and Pain Medicine, UNIVAQ, L’Aquila, Italy Researcher, University of Roma, Italy Researcher, University of Hamburg, Germany Researcher CNR-NIH, Albert Einstein College of Medicine, Yeshiva University, New York, NY, USA

Hebei Provincial Key Laboratory for Liver Cirrhosis and Portal Hypertension, Xingtai People’s HospitalHebei Provincial Key Laboratory for Liver Cirrhosis and Portal Hypertension, Xingtai People’s Hospital, Hebei, China
Artificial intelligence; Cirrhosis; Portal hypertension; Liver cancer

Laboratory of Precision Therapeutics, Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China hospital, Sichuan University, Chengdu, China
Cancer pharmacology; Experimental therapeutics; Tumor microenvironment; Drug delivery; Nanomedicine

Pulmonary Department, "General Clinic Euromedica" Private Hospital, Thessaloniki, Greece
Lung diseases; Gene therapy; Design, development, and therapy of novel drugs
Dr. Pavlos Zarogoulidis, M.D, Ph. D Director of Pulmonary Department, ``General Clinic Euromedica`` Private Hospital, Thessaloniki, Greece have three MS.c in ``Clinical Pharmacology``, ``Sleep Medicine`` and ``Thyroid Gland Disease and Treatment ``and my Ph. D is regarding inhaled chemotherapy for lung cancer. In my everyday practice I perform diagnosis for lung cancer with bronchoscopy, radial and convex probe endobronchial ultrasound and medical thoracoscopy.

Key Laboratory for Biomedical Engineering of Ministry of EducationDepartment of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
Flexible stretchable electronic skin and implantable bioelectrodes; Bioelectricity; Multidimensional mechanics; Optical imaging; Multimodal synergistic sensing and feedback technologies

School of life sciences, Zhengzhou University, Zhengzhou, China
Intestinal Stem Cells; Cancer Stem Cells; Niche; Tumorigenesis; Epigenetic Regulation; Noncoding RNA
Professor Zhu Pingping has studied the microenvironmental regulation and epigenetic regulation of long-term stem cells (adult stem cells and tumor stem cells), identified multiple stemness regulatory factors and regulatory pathways of tumor stem cells and intestinal stem cells, and discovered a new model of immune microenvironment regulation of intestinal stem cells. Professor Zhu Pingping has successively presided over the China Association for Science and Technology Young Talent Support Project, the Postdoctoral Innovation Talent Support Program, the National Natural Science Foundation of China General Project, and the Excellent Youth Project. He has published more than ten papers as the first author or general author in journals such as Nat Immunol, Nat Cell Biol, Nat Struct Mol Biol, J Clin Invest and Nat Commun, and has published more than 30 SCI articles in total, with a total impact factor of more than 300 and a citation rate of more than 1,000 times in two years. He has won the Special Award of the President of the Chinese Academy of Sciences and the First Prize of Beijing Science and Technology Progress.

Department of Biochemistry and Molecular Biology II, Complutense University of Madrid, Madrid, Spain
Abdominal obesity; Cancer research; Energy metabolism; Fat insulin resistance; Insulin signaling; Lipids; Metabolic diseases; Metabolic endocrinology; Metabolism

Department of Medical Biology, Section Clinical Anatomy & Embryology, Amsterdam Reproduction & Development Research institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
Cardiovascular physiology; Embryology and development